Me‘nie`re's disease: epidemiology, etiology, diagnostics, management

Cover Page

Cite item

Full Text

Abstract

Ménière's disease is an inner ear disorder, characterized by recurrent attacks of vertigo associated with fluctuating hearing loss, tinnitus and a sense of fullness in the ear and a fluctuating hearing loss. In this paper we present a review on epidemiology and incidence of this disease, pathogenesis of endolymphatic hydrops and diagnostic tools, including pure tome audiometry, electrocochleography, dehydratation test, videonystagmography, caloric test, video head impulse test and vestibular evoked myogenic potentials. Different treatment options, such as salt reduction diet, betahistine, diuretics, steroids, gentamicin, vestibular rehabilitation, Meniett therapy, endolymphatic sac and duct surgery, vestibular nerve section and surgical ablation, are also discussed.

About the authors

V. T Palchun

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: lorrsmu@mail.ru
д-р мед. наук, чл.-корр. РАН, засл. деят. науки РФ, проф. каф. оториноларингологии лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

A. L Guseva

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: alexandra.guseva@gmail.com
канд. мед. наук, доц. каф. оториноларингологии лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

Y. V Levina

N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Email: jlevina@mail.ru
канд. мед. наук, доц. каф. оториноларингологии лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1

References

  1. Minor L.B, Schessel D.A, Carey J.P. Ménière's disease. Curr Opin Neurol 2004; 17 (1): 9-16.
  2. Сагалович Б.М., Пальчун В.Т. Болезнь Меньера. М.: Московское информационное агентство, 1999.
  3. Baloh R.W. Prosper Meniere and his disease. Arch Neurol 2001; 58: 1151-6.
  4. Arenberg I.K, Countryman L.F, Bernstein L.H.Jr, Shambaugh G.E. Van Gogh had Meniere’s disease and not epilepsy. JAMA 1990; 264: 491-3.
  5. Stephens D, Mudry A. Ménière’s disorder: a short history. Audiol Med 2012; 10: 153-9.
  6. Alexander T.H, Harris J.P. Current epidemiology of Meniere's syndrome. Otolaryngol Clin North Am 2010; 43 (5): 965-70. doi: 10.1016/j.otc.2010.05.001.
  7. Choung Y.H, Park K, Kim C.H et al. Rare cases of Ménière’s disease in children. J Laryngol Otol 2006; 120 (4): 343-52.
  8. Shojaku H, Watanabe Y, Fujisaka M et al. Epidemiologic characteristics of definite Ménière’s disease in Japan. A long - term survey of Toyama and Niigata prefectures. ORL J Otorhinolaryngol Relat Spec 2005; 67 (5): 305-9.
  9. Neuhauser H.K, Von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005; 65 (6): 898-904.
  10. Brandt T, Dieterich M, Strupp M. Vertigo and dizziness - common complaints. 2. London: Springer; 2013.
  11. Левина Ю.В., Кунельская Н.Л., Красюк А.А., Бауш Я.А. Эпидемиологическая характеристика больных, страдающих кохлеовестибулярными нарушениями при гидропсе лабиринта. Вестн. оториноларингологии. 2011; 4: 40-2.
  12. Gürkov R, Flatz W, Louza J et al. In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Ménière’s disease. Otol Neurotol 2012; 33 (6): 1040-5. doi: 10.1097/MAO.0b013e31825d9a95.
  13. Schuknecht H.F. Meniere's disease: a correlation of symptomatology and pathology. Laryngoscope 1963; 73: 651-65.
  14. Yeh T.H, Herman P, Tsai M.C et al. A cationic nonselective stretch - activated channel in the Reissner's membrane of the guinea pig cochlea. Am J Physiol 1998; 274 (3 Pt. 1): C566-76.
  15. Tsuji K, Velázquez-Villaseñor L, Rauch S.D et al. Temporal bone studies of the human peripheral vestibular system. Meniere's disease. Ann Otol Rhinol Laryngol Suppl 2000; 181: 26-31.
  16. Honrubia V. Pathophysiology of Meniere's disease. Meniere's Disease (Ed. J.P.Harris) 1999; p. 231-60; Pub: Kugler (The Hague).
  17. Merchant S.N, Adams J.C.Jr, Nadol J.B. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005; 26 (1): 74-81.
  18. Selmani Z, Marttila T, Pyykkö I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol 2005; 262 (4): 331-4.
  19. Tyrrell J.S, Whinney D.J, Ukoumunne O.C et al. Prevalence, associated factors, and comorbid conditions for Ménière's disease. Ear Hear 2014; 35 (4): e162-9. doi: 10.1097/AUD.0000000000000041.
  20. Lee J.M, Kim M.J, Jung J et al. Genetic aspects and clinical characteristics of familial Meniere's disease in a South Korean population. Laryngoscope 2015; 125 (9): 2175-80. doi: 10.1002/lary.25207.
  21. Candreia C, Schmuziger N, Gürtler N. Molecular analysis of aquaporin genes 1 to 4 in patients with Ménière's disease. Cell Physiol Biochem 2010; 26 (4-5): 787-92. doi: 10.1159/000322346.
  22. Cabrera S, Sanchez E, Requena T et al. Intronic variants in the NFKB1 gene may influence hearing forecast in patients with unilateral sensorineural hearing loss in Meniere's disease. PLoS One 2014; 9 (11): e112171. doi: 10.1371/journal.pone.0112171.
  23. Крюков А.И., Федорова О.К., Антонян Р.Г. и др. Клинические аспекты болезни Меньера. М.: Медицина, 2006.
  24. Nabi S, Parnes L.S. Bilateral Ménière's disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17 (5): 356-62. doi: 10.1097/MOO.0b013e3283304cb3.
  25. Huppert D, Strupp M, Brandt T. Long - term course of Menière's disease revisited. Acta Otolaryngol 2010; 130 (6): 644-51. doi: 10.3109/00016480903382808.
  26. Zingler V.C, Cnyrim C, Jahn K et al. Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 2007; 61 (6): 524-32.
  27. Odkvist L.M, Bergenius J. Drop attacks in Meniere’s disease. Acta Otolaryngol 1988; 455: 82-5.
  28. Lopez-Escamez J.A, Carey J, Chung W.H et al. Diagnostic criteria for Menière's disease. Consensus document of the Bárány Society, the Japan Society for Equilibrium Research, the European Academy of Otology and Neurotology (EAONO), the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Korean Balance Society. Acta Otorrinolaringol Esp 2016; 67 (1): 1-7. doi: 10.1016/j.otorri.2015.05.005.
  29. Friberg U, Stahle J, Svedberg A. The natural course of Meniere's disease. Acta Otolaryngol Suppl 1984; 406: 72-7.
  30. Palomar-Asenjo V, Boleas-Aguirre M.S, Sánchez-Ferrándiz N, Perez Fernandez N. Caloric and rotatory chair test results in patients with Ménière's disease. Otol Neurotol 2006; 27 (7): 945-50.
  31. Oosterveld W.J. Menière's disease, signs and symptoms. J Laryngol Otol 1980; 94 (8): 885-92.
  32. Black F.O, Kitch R. A review of vestibular test results in Meniere's disease. Otolaryngol Clin North Am 1980; 13 (4): 631-42.
  33. Park H.J, Migliaccio A.A, Della Santina C.C et al. Search - coil head - thrust and caloric tests in Ménière's disease. Acta Otolaryngol 2005; 125 (8): 852-7.
  34. Mc Garvie L.A, Curthoys I.S, Mac Dougall H.G, Halmagyi G.M. What does the head impulse test versus caloric dissociation reveal about vestibular dysfunction in Ménière's disease? Ann NY Acad Sci 2015; 1343: 58-62. doi: 10.1111/nyas.12687.
  35. Bronstein A. Oxford Textbook of Vertigo and Imbalance. Barcelona: Oxford University Press, 2013.
  36. Rauch S.D, Zhou G, Kujawa S.G et al. Vestibular evoked myogenic potentials show altered tuning in patients with Ménière's disease. Otol Neurotol 2004; 25 (3): 333-8.
  37. Egami N, Ushio M, Yamasoba T et al. The diagnostic value of vestibular evoked myogenic potentials in patients with Meniere's disease. J Vestib Res 2013; 23 (4-5): 249 57. doi: 10.3233/VES-130484.
  38. Пальчун В.Т., Левина Ю.В., Кадымова М.И. и др. Способ диагностики кохлеарного гидропса. Патент на изобретение RUS 2226066 26.12.2001.
  39. Левина Ю.В. Особенности аудиологической диагностики кохлеовестибулярных нарушений, обусловленных гидропсом внутреннего уха. Вестн. оториноларингологии. 2005; 6: 25-7.
  40. Кунельская Н.Л., Тардов М.В., Байбакова Е.В. и др. Дифференциальная диагностика системных головокружений - масок болезни Меньера. Земский врач. 2014; 2 (23): 15-8.
  41. Pyykkо I, Magnusson M, Schalеn L, Enbom H. Pharmacological treatment of vertigo. Acta Otolaryngol Suppl 1988; 455: 77-81.
  42. Antonio S.M, Friedman R. Meniere’s Disease. In: R.K.Jackler, D.E.Brackmann, eds. Neurotology. Philadelphia: Elsevier, 2005; p. 621-38.
  43. Morse G.G, House J.W. Changes in Ménière’s disease responses as a function of the menstrual cycle. Nurs Res 2001; 50: 286-92.
  44. Söderman A.C, Möller J, Bagger-Sjöbäck D et al. Stress as a trigger of attacks in Menière’s disease. A case - crossover study. Laryngoscope 2004; p. 1843-8.
  45. Кунельская Н.Л., Гусева А.Л., Чистов С.Д. Уровень b - эндорфина, хронический стресс и депрессия при вестибулярной патологии. Вестн. оториноларингологии. 2015; 1: 12-6.
  46. Akioka K. Pathophysiological study on active endolymphatic hydrops in guinea pig: with stress stimulations [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 1990; 93: 1250-7.
  47. Van Cruijsen N, Dullaart R.P, Wit H.P, Albers F.W. Analysis of cortisol and other stress - related hormones in patients with Ménière’s disease. Otol Neurotol 2005; 26: 1214-9.
  48. Ярославская М.А., Петровская А.Н. Психологические особенности пациентов с болезнью Меньера и их психосоциальная адаптация. Вестн. оториноларингологии. 2013; 6: 99-101.
  49. Orji F. The Influence of Psychological Factors in Meniere's Disease.Ann Med Health Sci Res. 2014; 4 (1): 3-7. doi: 10.4103/2141-9248.126601.
  50. Bolignano D, Coppolino G, Criseo M et al. Aquaretic agents: what’s beyond the treatment of hyponatremia? Curr Pharm Des 2007; 13: 865-71.
  51. Ramos Alcocer R, Ledezma Rodríguez J.G et al. Use of betahistine in the treatment of peripheral vertigo. Acta Otolaryngol 2015; 135 (12): 1205-11. doi: 10.3109/00016489.2015.1072873.
  52. Seyed-Tootoonchi S.J, Ghiasi S, Shadara P et al. Hearing function after betahistine therapy in patients with Ménière's disease. Braz J Otorhinolaryngol 2015; pii: S1808-8694(15)00234-7. doi: 10.1016/j.bjorl.2015.08.021.
  53. Bertlich M, Ihler F, Freytag S et al. Histaminergic H3-Heteroreceptors as a Potential Mediator of Betahistine-Induced Increase in Cochlear Blood Flow. Audiol Neurootol 2015; 20 (5): 283-93. doi: 10.1159/000368293.
  54. Lezius F, Adrion C, Mansmann U et al. High - dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series. Eur Arch Otorhinolaryngol 2011; 268 (8): 1237-40. doi: 10.1007/s00405-011-1647-2.
  55. Thirlwall A.S, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2006; 3: CD003599.
  56. Coelho D.H, Lalwani A.K. Medical management of Ménière's disease. Laryngoscope 2008; 118 (6): 1099-108. doi: 10.1097/MLG.0b013e31816927f0.
  57. Foster C.A. Optimal management of Ménière's disease. Ther Clin Risk Manag 2015; 11: 301-7. doi: 10.2147/TCRM.S59023.
  58. Morales-Luckie E, Cornejo-Suarez A, Zaragoza-Contreras M.A, Gonzalez-Perez O. Oral administration of prednisone to control refractory vertigo in Ménière’s disease: a pilot study. Otol Neurotol 2005; 26 (5): 1022-6.
  59. Lavigne P, Lavigne F, Saliba I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 2015. doi: 10.1007/s00405-015-3689-3.
  60. Eisenberg D.M, Davis R.B, Ettner S.L et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow - up national survey. JAMA 1998; 280: 1569-75.
  61. Lall M. Ménière's disease and the grommet (a survey of its therapeutic effects). J Laryngol Otol 1969; 83 (8): 787-91.
  62. Densert O, Carlborg B, Stagg J. Transmission of a low frequency pressure steps to the perilymphatic fluid. Acta Otolaryngol 1981; 91: 55-64.
  63. Gates G.A, Green J.D.Jr, Tucci D.L, Telian S.A. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch Otolaryngol Head Neck Surg 2004; 130 (6): 718-25.
  64. Zhang S.L, Leng Y, Liu B et al. Meniett Therapy for Ménière's Disease: An Updated Meta - analysis. Otol Neurotol 2016.
  65. Shepard N.T, Telian S.A, Smith-Wheelock M, Raj A. Vestibular and balance rehabilitation therapy. Ann Otol Rhinol Laryngol 1993; 102: 198-205.
  66. Gottshall K.R, Hoffer M.E, Moore R.J, Balough B.J. The role of vestibular therapy in the treatment of Meniere’s disease. Otolaryngol Head Neck Surg 2005; 133: 326-8.
  67. Feenstra L. The management of tinnitus with or without Menière’s disease. Acta Otolaryngol Suppl 1997; 526: 47-9.
  68. Locke R.R, Shaw-Dunn J, O'Reilly B.F. Endolymphatic sac surgical anatomy and transmastoid decompression of the sac for the management of Ménière's disease. J Laryngol Otol 2014; 128 (6): 488-93. doi: 10.1017/S0022215114001017.
  69. Лиленко А.С. Сравнение отдаленных результатов дренирования эндолимфатического мешка с его шунтированием и без пациентов с болезнью Меньера. Рос. оториноларингология. 2014; 1: 140-3.
  70. Пальчун В.Т., Левина Ю.В. Рассечение эндолимфатического протока при болезни Меньера. Вестн. оториноларингологии. 2003; 3: 4-6.
  71. Папина Н.А. Современные аспекты хирургического лечения болезни Меньера. Вестн. оториноларингологии. 2000; 4: 67-70.
  72. Li C.S, Lai J.T. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Meniere’s disease: an interdisciplinary review. Acta Neurochir (Wien) 2008; 150 (7): 655-61; discussion 661. doi: 10.1007/s00701-007-1462-0.
  73. Pullens B, Van Benthem P.P. Intratympanic gentamicin for Ménière’s disease or syndrome. Cochrane Database Syst Rev 2011; 3: CD008234.
  74. Postema R.J, Kingma C.M, Wit H.P et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire’s disease: a prospective, double - blind, randomized, placebocontrolled trial. Acta Otolaryngol 2008; 128: 876-80.
  75. Крюков А.И., Антонян Р.Г., Гаров Е.В., Шеремет А.С. Лазерная хирургия внутреннего уха. М.: Мир Урании, 2009.

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies